Schaper Benz & Wise Investment Counsel Inc Organon & Co. Transaction History

Schaper Benz & Wise Investment Counsel Inc

$1.21 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$10.95 - $17.32 $28,240 - $44,668	-2,579 Reduced 14.66%	15,018 $216,000
Q3 2023 Oct 11, 2023	SELL	$16.59 - $23.77 $497,965 - $713,480	-30,016 Reduced 63.04%	17,597 $305,000
Q2 2023 Jul 17, 2023	SELL	$19.27 - $24.63 $76,617 - $97,928	-3,976 Reduced 7.71%	47,613 $990,000
Q1 2023 May 01, 2023	SELL	$21.42 - $32.08 $79,296 - $118,760	-3,702 Reduced 6.7%	51,589 $1.21 Million
Q4 2022 Jan 25, 2023	SELL	$23.31 - $28.61 $34,801 - $42,714	-1,493 Reduced 2.63%	55,291 $0
Q3 2022 Oct 17, 2022	BUY	$23.4 - $34.25 $15,163 - $22,194	648 Added 1.15%	56,784 $1.33 Million
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $180,145 - $221,341	-5,690 Reduced 9.2%	56,136 $1.9 Million
Q1 2022 Apr 29, 2022	SELL	$30.45 - $39.36 $65,711 - $84,938	-2,158 Reduced 3.37%	61,826 $2.16 Million
Q4 2021 Feb 10, 2022	BUY	$28.67 - $37.13 $48,308 - $62,564	1,685 Added 2.7%	63,984 $1.95 Million
Q3 2021 Oct 27, 2021	BUY	$28.63 - $35.64 $1.22 Million - $1.51 Million	42,502 Added 214.69%	62,299 $2.04 Million
Q2 2021 Jul 29, 2021	BUY	$28.45 - $38.0 $563,224 - $752,286	19,797 New	19,797 $599,000

Others Institutions Holding OGN

# of Institutions

792

Shares Held

203M

Call Options Held

1.71M

Put Options Held

865K

Black Rock Inc. New York, NY

32.6M
Shares

$507 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.2M
Shares

$470 Million
0.01% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.2M
Shares

$174 Million
0.41% of portfolio
Massachusetts Financial Services CO Boston, MA

9.76M
Shares

$152 Million
0.06% of portfolio
State Street Corp Boston, MA

8.98M
Shares

$140 Million
0.01% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schaper Benz & Wise Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schaper Benz & Wise Investment Counsel Inc with notifications on news.

Account